StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Other Medicines (Established / Legacy Brands) by Quarter

Other Medicines (Established / Legacy Brands) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Other Medicines (Established / Legacy Brands): $230M in Q2 2026, down 4.6% from a year earlier. That is the lowest of the 42 quarters on record here.

Latest, Q2 2026
230
Period ended Jun 30, 2026
Change on a year earlier
-4.6%
241 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Other Medicines | | 230 | | ( 4 ) | | ( 6 ) | | 19 | | ( 9 ) | | 166 | | ( 10 ) | | ( 13 ) | | 25 | | 52 | | 51 | | 20 | | 12 | | 14”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Therapy Area & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Medicines (Established / Legacy Brands) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026230-4.6%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026250-6.4%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025231-7.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025233-12.1%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025241-9.7%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025267-8.9%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024249-6.4%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024265-10.8%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024267-11.3%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024293-6.1%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023266-29.8%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023297-26.5%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023301-28.0%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023312-26.6%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022379-54.1%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022404-25.0%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up other Medicines (Established / Legacy Brands)

Cite this data

StockData. (2026). AstraZeneca Other Medicines (Established / Legacy Brands) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-other-meds-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.